Connect with us

Accountability

Uninsured Americans will no longer receive free COVID treatments or testing

Published

on

Many uninsured Americans will soon be required to pay for COVID-19 treatments and testing after a federal program that reimbursed providers for virus-related care to expire this week.

The White House said it will end the reimbursement program, which was set up in March 2020 under then-President Trump, because it has exhausted its funding. Money from the program went toward paying hospitals and other health care providers for the treatment, testing and vaccination of those without insurance, regardless of immigration status.

“Providers will no longer be able to submit claims for providing these services to uninsured individuals, forcing providers to either absorb the cost or turn away people who are uninsured, increasing the disparity in access to critically needed health care and putting additional burdens on safety net providers,” the White House said in a statement last week.

A separate program, the HRSA COVID-19 Coverage Assistance Fund, is available to reimburse providers for COVID-19 vaccine administration to underinsured individuals whose health plan either does not include COVID-19 vaccination as a covered benefit or covers COVID-19 vaccine administration but with cost-sharing.

But the program stopped accepting claims submitted after 11:59 p.m. Tuesday for COVID-19 testing or treatment “due to lack of sufficient funds,” according to the HRSA website. At 11:59 p.m. EST on April 5, the Uninsured Program will also stop accepting vaccination claims.

Advertisement

The cost of a COVID-19 test varies depending on the type. Most pharmacies have provided no-cost PCR tests to those with or without insurance. The cost of a voluntary PCR COVID-19 test, one that is not covered by insurance, is $139 at CVS, which includes $39 for services provided by MinuteClinic or CVS Pharmacy and $100 for the lab services, according to the retail pharmacy’s website.

Desert Healthcare District and Foundation CEO Dr. Conrado Bárzaga said at Tuesday’s board meeting the change is “worrisome” and will “have an impact on our population.”

Print Friendly, PDF & Email
Advertisement
Click to comment
0 0 votes
Article Rating
Subscribe
Notify of

This site uses Akismet to reduce spam. Learn how your comment data is processed.

0 Comments
Inline Feedbacks
View all comments

Trending

0
Would love your thoughts, please comment.x
()
x